Full-Time

Quality Control Sample Coordinator 1

Posted on 5/9/2026

PCI Pharma Services

PCI Pharma Services

1-10 employees

Pharmaceutical packaging and contract services

No salary listed

Bedford, NH, USA

In Person

Category
Biology & Biotech (1)
Required Skills
Inventory Management
Requirements
  • 1-3 years relevant business experience or education
  • High school diploma required
  • Proficient in MS Office
  • Must have strong attention to detail as well as ability to work in a cross-functional team environment
  • Professional interpersonal skills and the ability to communicate well orally and in writing
  • Ability to multi-task in a dynamic environment with changing priorities
  • Ability to work independently as well as on a team, with limited supervisory oversight
Responsibilities
  • Ordering, receipt and management of QC Laboratory supplies, including chemicals and consumable materials in accordance with cGMP and procedural requirements.
  • Monitoring, ordering and maintenance of the primary QC laboratory supply KANBAN system.
  • Receipt of reference standards from internal teams, clients and external suppliers, including review of documentation to meet internal requirements.
  • Management of the reference standard inventory, including communication with internal project management teams to request additional client supplied materials and updated documentation for materials currently in inventory.
  • Inspection, review and receipt of incoming samples for testing in the QC laboratory and/or contract laboratories. Verification of information against specifications, protocols and other documentation to ensure accurate material receipt and compliance.
  • Maintain sample tracking and chain of custody records in accordance with cGMP and procedural requirements.
  • Complete data entry in validated systems and business tools with a high degree of accuracy.
  • Request, assemble, and distribute QC testing data packets for support of in-process, lot release, raw material, and stability testing.
  • Coordinating testing with external contract laboratories. Request quotes and POs as needed, and coordinate with project management for client managed testing.
  • Provide documentation and samples to the materials management team to process for shipment.
  • Review and reconcile completed testing packets prior to submission to QA Document Control for long term storage.
  • Request and maintain Quality Control logbooks in accordance with cGMP and procedural requirements
  • Perform dimensional inspections on containers and closures materials in quarantine.
  • Assist with sampling container and closure materials as needed.
Desired Qualifications
  • Master Control or equivalent experience working with a validated document system preferred
  • Basic understanding of cGMP, GDP, and laboratory workflows preferred
  • Laboratory experience and familiarity with chemical handling preferred

PCI Pharma Services offers end-to-end pharmaceutical packaging and related services, including Folding Cartons, Labels, Contract Packaging, Clinical Services, and Brand Protection. It serves as a one-stop source for healthcare product developers and manufacturers, handling carton and label production, packaging operations, clinical services, and brand protection under one roof. The company stands out with eight decades of experience, strict cGMP and ISO compliance, lean manufacturing, ongoing R&D, and comprehensive employee training, security, hygiene, and inspection practices. Its goal is to be a trusted, end-to-end packaging partner that delivers reliable, compliant, and scalable packaging solutions, so clients can focus on their core business.

Company Size

1-10

Company Stage

Debt Financing

Total Funding

$4B

Headquarters

Burlington, Canada

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • GLP-1 surge drives demand for PCI's prefilled syringes and autoinjectors.
  • Oncology-CNS pipelines favor PCI's patient-centric drug-device combinations.
  • Bain Capital's $10B valuation fuels $1B capacity expansions through 2028.

What critics are saying

  • San Diego isolator line delays to H1 2028 cede contracts to Lonza.
  • Novo Nordisk's Catalent acquisition slashes external CDMO fill-finish availability.
  • PE backers force divestitures if biotech funding dries post-2025.

What makes PCI Pharma Services unique

  • PCI integrates sterile fill-finish with drug-device assembly for end-to-end injectables.
  • Ajinomoto Althea acquisition adds rare US high-potent ADC sterile filling expertise.
  • AVI systems inspect 75 million vials annually, scaling quality without bottlenecks.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at PCI Pharma Services who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

401(k) Retirement Plan

Health Savings Account/Flexible Spending Account

Company News

BioProcess International
Aug 15th, 2025
Building a better facility: BPI tours PCI manufacturing plant in Bedford

On the last day of June 2025's BIO conference in Boston, Massachusetts, contract development and manufacturing organization (CDMO) PCI Pharma Services bused a crowd of delegates to its manufacturing site in Bedford, New Hampshire where it hosted a tour of its 50,000 square-foot expansion.

Montgomery County
Jul 24th, 2025
PCI Pharma Services Valued at $10B

PCI Pharma Services in Northeast Philadelphia has received a multibillion-dollar investment from Bain Capital and Kohlberg, valuing the company at $10 billion. Kohlberg had previously invested in PCI, while Bain is a new investor. The investment will help PCI expand its services and geographic reach. The company currently operates 38 sites across seven countries and employs over 7,500 people.

JD Supra
Jul 16th, 2025
Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital and Kohlberg Invest in PCI Pharma

Healthcare & life sciences Private Equity deal tracker: Bain Capital and Kohlberg invest in PCI Pharma.

FinSMEs
Jul 15th, 2025
PCI Pharma Services Receives Investment from Mubadala, Bain Capital, and Kohlberg

PCI Pharma, a Philadelphia, PA-based contract development and manufacturing organization (CDMO) focused on biotherapies, received an investment from Bain Capital, Kohlberg, and Mubadala Investment Company.

MarketScreener
Jul 14th, 2025
PCI Pharma Services receives new funding

PCI Pharma Services announced it received a new round of funding on July 14, 2025. The funding was co-led by new investor Bain Capital, LP, and returning investor Kohlberg & Company, L.L.C. Additional participation came from returning investors Mubadala Investment Company PJSC and Partners Group Holding AG.